OR WAIT null SECS
February 02, 2019
Biosimilars, pricing strategies, and technology will influence growth in spending on drugs.
Political instability is causing uncertainty in Europe and wreaking havoc with US regulatory timeframes.
January 18, 2019
The new year has started with a bang in terms of mergers and acquisitions.
December 02, 2018
Bio/pharma companies cannot spell success without solving all elements of quality programs.
Taking stock on the ‘big-ticket’ news items, both good and bad, from the past 12 months.
November 02, 2018
Survey results and record attendance show positive signs for various bio/pharma regions.
November 01, 2018
… Brexit may be a bumpy ride. Here, the new European editor of the PharmTech Group, Felicity Thomas, discusses Brexit and its implications for the pharma industry.
September 02, 2018
Sharing know-how can help resolve common bio/pharma technical challenges.
July 02, 2018
After 30 years of biologic-drug advances, the industry and patients still have a lot to learn.
June 02, 2018
By minding knowledge gaps, bio/pharma companies can avoid development pitfalls.